Precision Optics Corporation, Inc. (POCI)
NASDAQ: POCI · Real-Time Price · USD
5.00
-0.05 (-0.99%)
At close: Nov 12, 2026, 4:00 PM EST
5.00
0.00 (0.00%)
After-hours: Nov 12, 2026, 4:17 PM EST
Company Description
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.
It also provides components and assemblies defense contractors, aerospace and industrial customers. It markets its products to medical device companies.
Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Littleton, Massachusetts.
Precision Optics Corporation, Inc.
| Country | United States |
| Founded | 1982 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 108 |
| CEO | Joseph Forkey |
Contact Details
Address: 550 King Street, Bldg. A Littleton, Massachusetts 01460 United States | |
| Phone | 978 630 1800 |
| Website | poci.com |
Stock Details
| Ticker Symbol | POCI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000867840 |
| CUSIP Number | 740294400 |
| ISIN Number | US7402944000 |
| Employer ID | 04-2795294 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Richard E. Forkey | Founder, Advisor to the Chief Executive Officer and Director Emeritus |
| Dr. Joseph N. Forkey | Chief Executive Officer, President, Treasurer and Director |
| Wayne M. Coll | Chief Financial Officer and Secretary |
| Joseph Traut | Chief Operating Officer |
| Peter Thier | Senior Vice President of Sales and Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | 8-K | Current Report |
| Oct 30, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Oct 27, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Oct 27, 2026 | DEF 14A | Other definitive proxy statements |
| Sep 28, 2026 | 8-K | Current Report |
| Sep 28, 2026 | 10-K | Annual Report |
| May 14, 2026 | SCHEDULE 13G/A | Filing |
| May 13, 2026 | 10-Q | Quarterly Report |
| Mar 31, 2026 | SCHEDULE 13D/A | Filing |
| Mar 30, 2026 | 8-K | Current Report |